Article
Comparison between molecular and histological IDH-wild-type glioblastoma and extensive subgroup analysis of IDH-wild-type astrocytic tumors without genomic glioblastoma-defining alterations.
Journal of neuro-oncology - 10 Jun 2026
Seifert Anna M, Richter Sven, Sagerer André, Lemnian Ioana, Herold Sylvia, Brückmann Sascha, Emmanouilidis Dimitrios, Alkhatib Majd, Eyüpoglu Ilker Y, Williams Erik A, Cahill Daniel P, Juratli Tareq A
Abstract excerpt
PURPOSE: This study compares clinical characteristics and survival between molecular (MolGBM) and histological IDH-wild-type (IDH-WT) glioblastoma (HistGBM), and further characterizes histological lower-grade IDH-WT astrocytic tumors without genomic GBM-defining alterations. METHODS: Adult patients with histologically lower-grade IDH-WT astrocytoma (WHO grade 2-3) and available tumor tissue were included. Tumors...
Topics
- Humans
- Isocitrate Dehydrogenase
- Glioblastoma
- Female
- Male
- Brain Neoplasms
- Middle Aged
- Adult
- Mutation
- Telomerase
